Skip to main content

A critical evaluation of the European drug strategy: Has it brought added value to drug policy making at the national level?

Chatwin, Caroline (2013) A critical evaluation of the European drug strategy: Has it brought added value to drug policy making at the national level? International Journal of Drug Policy, 24 (3). pp. 251-256. ISSN 0955-3959. (doi:10.1016/j.drugpo.2012.11.001) (The full text of this publication is not currently available from this repository. You may be able to access a copy if URLs are provided)

The full text of this publication is not currently available from this repository. You may be able to access a copy if URLs are provided. (Contact us about this Publication)
Official URL
http://dx.doi.org/10.1016/j.drugpo.2012.11.001

Abstract

Background: The current European Drug Strategy (EDS) and attendant Action Plan come to an end this year signalling a period of evaluation of and reflection on whether they have achieved their aims and objectives. Methodology: This opinion based article seeks to add a critical and academic evaluation to the mix, which is focused on determining the extent to which the European drug policy has brought added value to drug policy that is formulated at the national level, in accordance with the principle of subsidiarity. The analysis presented here examines the five key areas defined by the EDS: coordination, demand reduction, supply reduction, international cooperation and information, research and evaluation. Results: It suggests that, while clear benefits have been brought in the realm of information, research and evaluation and the development of harm reduction measures, there is still significant progress yet to be made. Conclusion: It finds that neither the Commission's dedication to increasing focus on law-enforcement methods, nor the Council's prescription for 'more of the same' are particularly beneficial to the development of European drug policy. Instead, the priorities should be building on areas where added value has been engendered and on allowing diversity in policy to flourish.

Item Type: Article
DOI/Identification number: 10.1016/j.drugpo.2012.11.001
Uncontrolled keywords: European drug policy analysis, European drug policy harmonisation, European drug strategy, article, drug cost, drug industry, drug policy, drug traffic, Europe, health care organization, health care policy, information processing, law enforcement, medical literature, methodology, priority journal, protocol compliance
Subjects: H Social Sciences
Divisions: Faculties > Social Sciences > School of Social Policy Sociology and Social Research
Depositing User: Mita Mondal
Date Deposited: 11 Dec 2013 10:19 UTC
Last Modified: 06 Feb 2020 04:08 UTC
Resource URI: https://kar.kent.ac.uk/id/eprint/37486 (The current URI for this page, for reference purposes)
Chatwin, Caroline: https://orcid.org/0000-0002-7124-2264
  • Depositors only (login required):